Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Oldham

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Respiratory Medicine|November 28, 2016
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung diseaseJustin M Oldham, Cathryn Lee, Eleanor Valenzi, et al.
Respiratory Medicine: X|May 27, 2020
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survivalCatherine A Bonham, Cara L Hrusch, Kelly M Blaine, et al.
ERJ Open Research|July 19, 2023
Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosisJustin M Oldham, Kirk W Johnson, Gesa J Albers, et al.
Archives of Pathology & Laboratory Medicine|May 4, 2017
Interstitial Pneumonia With Autoimmune Features: Value of HistopathologyAyodeji Adegunsoye, Justin M Oldham, Eleanor Valenzi, et al.
Chest|May 26, 2020
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSAAyodeji Adegunsoye, Julie M Neborak, Daisy Zhu, et al.
BMC Pulmonary Medicine|February 10, 2018
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumoniaJustin M Oldham, Leah J Witt, Ayodeji Adegunsoye, et al.
BMC Pulmonary Medicine|December 13, 2022
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trialAnna J Podolanczuk, John S Kim, Christopher B Cooper, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trialJustin M Oldham, Arata Azuma, Michael Kreuter, et al.
Chest|March 26, 2022
The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work GroupChad A Newton, Justin M Oldham, Carolyn Applegate, et al.
Thorax|June 10, 2022
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosisRichard J Allen, Amy Stockwell, Justin M Oldham, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Respiratory Medicine|November 28, 2016
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung diseaseJustin M Oldham, Cathryn Lee, Eleanor Valenzi, et al.
Respiratory Medicine: X|May 27, 2020
T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survivalCatherine A Bonham, Cara L Hrusch, Kelly M Blaine, et al.
ERJ Open Research|July 19, 2023
Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosisJustin M Oldham, Kirk W Johnson, Gesa J Albers, et al.
Archives of Pathology & Laboratory Medicine|May 4, 2017
Interstitial Pneumonia With Autoimmune Features: Value of HistopathologyAyodeji Adegunsoye, Justin M Oldham, Eleanor Valenzi, et al.
Chest|May 26, 2020
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSAAyodeji Adegunsoye, Julie M Neborak, Daisy Zhu, et al.
BMC Pulmonary Medicine|February 10, 2018
N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumoniaJustin M Oldham, Leah J Witt, Ayodeji Adegunsoye, et al.
BMC Pulmonary Medicine|December 13, 2022
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trialAnna J Podolanczuk, John S Kim, Christopher B Cooper, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trialJustin M Oldham, Arata Azuma, Michael Kreuter, et al.
Chest|March 26, 2022
The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work GroupChad A Newton, Justin M Oldham, Carolyn Applegate, et al.
Thorax|June 10, 2022
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosisRichard J Allen, Amy Stockwell, Justin M Oldham, et al.
Pageof 17